e-learning
resources
Virtual 2020
Pre-Congress Content
Diagnostic challenges in tuberculosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
A set of microRNA markers of active tuberculosis.
V. Evstifeev (Moscow, Russian Federation), G. Shepelkova (Moscow, Russian Federation), A. Ergeshova (Moscow, Russian Federation), A. Guskov (Moscow, Russian Federation), M. Bagirov (Moscow, Russian Federation), V. Yeremeev (Moscow, Russian Federation)
Source:
Virtual Congress 2020 – Diagnostic challenges in tuberculosis
Session:
Diagnostic challenges in tuberculosis
Session type:
E-poster session
Number:
536
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. Evstifeev (Moscow, Russian Federation), G. Shepelkova (Moscow, Russian Federation), A. Ergeshova (Moscow, Russian Federation), A. Guskov (Moscow, Russian Federation), M. Bagirov (Moscow, Russian Federation), V. Yeremeev (Moscow, Russian Federation). A set of microRNA markers of active tuberculosis.. 536
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
In silico analysis of tuberculosis and multiple sclerosis gene expression profiles reveals coregulated genes implicated in host response to pathogens.
Source: International Congress 2017 – Human susceptibility to tuberculosis
Year: 2017
A novel whole-blood miRNA signature for a rapid diagnosis of pulmonary tuberculosis
Source: Eur Respir J 2015; 45: 1173-1176
Year: 2015
Genes mediating risk for tuberculosis
Source: Annual Congress 2007 - Granuloma and the genes
Year: 2007
Characterisation of regulatory T-cells identified as CD4
+
CD25
high
CD39
+
in patients with active tuberculosis
Source: Annual Congress 2009 - From bench to bedside: diagnosis of tuberculosis
Year: 2009
The set of immunological tests for detection of active tuberculosis in children with latent infection
Source: International Congress 2019 – Paediatric tuberculosis
Year: 2019
Deficient
in silico
selection of
mycobacterium tuberculosis
(MTB) epitopes in tuberculosis (TB) patients
Source: Eur Respir J 2006; 28: Suppl. 50, 801s
Year: 2006
Expression of the PDCD1 gene to determine active tuberculosis infection in children and adolescents with latent TB infection
Source: Virtual Congress 2020 – The young, the old and extrapulmonary tuberculosis
Year: 2020
Progression towards the development of the universal highly discriminative panel of VNTR loci for
mycobacterium tuberculosis
genotyping
Source: Eur Respir J 2006; 28: Suppl. 50, 525s
Year: 2006
Quantitative scoring of an interferon-γ assay for differentiating active from latent tuberculosis
Source: Eur Respir J 2007; 30: 722-728
Year: 2007
Identification of reference genes in lung cancer from RNA-seq data
Source: International Congress 2017 – Lung cancer - basic science: the latest results from the bench
Year: 2017
Candidate surrogate markers for COPD identified by differential gene expression
Source: Eur Respir J 2002; 20: Suppl. 38, 583s
Year: 2002
Different genetics background of patients with latent tuberculosis infection versus active tuberculosis
Source: International Congress 2017 – Asthma genetics and genomics in patients and populations
Year: 2017
Application of the novel technique next gene sequencing for the determination of mycobacterium tuberculosis resistance in clinical samples
Source: Annual Congress 2013 –Tuberculosis diagnosis
Year: 2013
Multiple cytokine response to
mycobacterium tuberculosis
with a whole blood assay is useful to distinguish active from latent tuberculosis infection in a highly tuberculosis endemic country
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2
Year: 2014
Immune reactive profiling in subjects at risk of latent tuberculosis infection with TST(+)/IGRA(-) results.
Source: International Congress 2018 – Tuberculosis transmission and screening strategies
Year: 2018
Comparative analysis of M. tuberculosis drug susceptibility tests results in new multidrug-resistant tuberculosis cases and their confirmed contacts.
Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis
Year: 2020
The role of a new immuno-diagnostic test based on ESAT-6 epitopes in the screening of subjects with a clinical suspicion of active tuberculosis
Source: Eur Respir J 2003; 22: Suppl. 45, 166s
Year: 2003
The role of quantiferon tuberculosis gold test (Q) in diagnosing active tuberculosis (TB) and latent tuberculosis infection (LTI) in children
Source: Annual Congress 2008 - New tests and methods to diagnose tuberculosis infection and disease and to monitor treatment
Year: 2008
Comparison of Nramp1 gene polymorphisms among tuberculosis healthy workers with positive PPD and recently infected cases; host susceptibility to tuberculosis
Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept